AMICAS to Review Merge's Revised Offer

AMICAS Inc., a publicly traded medical technology company, said it would review the revised offer it received from Merge Healthcare now that it has been updated to include an executed definitive commitment letter for $200 million of financing from Morgan Stanley. AMICAS had previously agreed to sell itself to New York buyout firm Thoma Bravo, rejecting a rival offer from Merge because it did not have proof of guaranteed financing.

DealsNorth AmericaUSBriefs